Learn More-External Link
Trending at Lumira Ventures
Argos Therapeutics Publishes Research on the Immunosuppressive Properties of HIV
Learn More-External Link
Argos Therapeutics Presents Positive Transplantation and Immunosuppression Data for Soluble CD83 at the American Transplant Congress
DURHAM, N.C.–(BUSINESS WIRE)–Jun 1, 2009 – Argos Therapeutics today announced the presentation of new information on its soluble CD83 (sCD83) protein program in a poster session at the 2009 American Transplant Congress, held May 30-June 3 in Boston. The poster …
TransMolecular Announces Presentation of Data Highlighting Anti-angiogenic and Tumor-targeting Properties of TM601 at ASCO Annual Meeting
CAMBRIDGE, Mass.–(BUSINESS WIRE)–TransMolecular, Inc. today announced that new data highlighting the anti-angiogenic and tumor-targeting properties of TM601 will be discussed in a poster presentation and in a published abstract at the 45th Annual Meeting of the American Society of Clinical …
Device Offers Hope for Patients With Leaky Heart Valve – Forbes
May be option for those too sick for open-heart surgery, study suggests THURSDAY, May 7 (HealthDay News) — A new device offers hope for patients with a leaky heart valve who are too sick for open-heart surgery, …
Intriguing early results for device that reshapes enlarged, leaky heart valve
A fast, simple treatment option for patients too sick for surgery? LAS VEGAS, NV (May 7 2009) — An innovative device that acts like a belt to reshape an enlarged, leaky heart valve is providing a minimally invasive …
Archemix Appoints Ken Bate as President and Chief Executive Officer
May 06, 2009 09:00 AM Eastern Daylight Time CAMBRIDGE, Mass.–(BUSINESS WIRE)–Archemix Corp., a privately-held biotechnology company working to develop aptamer-based therapeutics, announced today the appointment of Kenneth M. Bate as President and Chief Executive Officer. Mr. Bate is a biotech …
Argos Therapeutics sees new promise for immunotherapeutics
Learn More-External Link
Roche and Pharmasset initiate dosing in Phase IIb hepatitis trial
Learn More-External Link
Resonant appoints Stephen Whisenhunt as new Vice President of Global Sales and Marketing
Learn More-External Link